Related Experiment Videos
Further studies on the hypercoagulable state of patients with Cushing's syndrome
Insights
Cushing's syndrome patients show increased blood clotting factors, suggesting a hypercoagulable state. This may be linked to cortisol's effects on coagulation and fibrinolysis.
Area of Science:
- Endocrinology
- Hematology
- Cardiovascular Medicine
Background:
- Cushing's syndrome is characterized by excessive cortisol exposure.
- Cortisol's impact on hemostasis is not fully understood.
- Previous studies suggest potential links between Cushing's syndrome and coagulation abnormalities.
Purpose of the Study:
- To investigate the hemostatic status in patients with Cushing's syndrome.
- To explore the relationship between cortisol levels and specific coagulation factors.
- To assess potential alterations in fibrinolytic activity.
Main Methods:
- Measured levels of coagulation factors (XII, XI, IX, VIII), plasminogen, and alpha 2-antiplasmin.
- Assessed Factor VIII antigen and ristocetin cofactor activity.
- Correlated coagulation parameters with mean arterial pressure.
Main Results:
- Elevated levels of Factors XII, XI, IX, VIII, plasminogen, and alpha 2-antiplasmin were observed.
- Significant correlations were found between mean arterial pressure and Factor VIII/XII activity.
- A hypercoagulable state in Cushing's syndrome appears confirmed, with potential endothelial dysfunction.
Conclusions:
- Cushing's syndrome is associated with a hypercoagulable state.
- Cortisol may mediate increased synthesis and release of coagulation factors.
- Decreased fibrinolytic activity is suspected due to elevated plasminogen and alpha 2-antiplasmin.
Abstract:
Factors XII, XI, IX and VIII, plasminogen and alpha 2-antiplasmin levels were found to be increased in a group of patients affected by Cushing's syndrome. High activity of these coagulation factors could be due to their increased release and synthesis mediated by cortisol. A significant correlation between the main arterial pressure and either factor VIII antigen, ristocetin cofactor or factor XII activity was found. Moreover a similar correlation between factor XII activity and either factor VIII antigen or ristocetin cofactor was seen. In conclusion, the presence of a hypercoagulable state in Cushing's syndrome seems confirmed. Synergic release of factor XII and factor VIII from endothelium could be due to high blood vessel tone secondary to hypercorticism. Finally, decreased fibrinolytic activity was suspected according to plasminogen and alpha 2-antiplasmin increase.